文献速递哮喘

成人及儿童哮喘诊断的挑战、未来方向与行动呼吁

Asthma diagnosis in adults and children: challenges, future directions, and a call to action.
PubMed 文献 · Lancet Respir Med · 2026-07-06

哮喘是全球最常见的慢性气道疾病,但误诊率高:20-70%的哮喘患者未确诊未治疗,约30%被标签为哮喘者实际无病。国际指南在诊断试验选择、排序和解读上存在差异,无单一试验能可靠确诊或排除哮喘,需多试验诊断策略。本文总结各指南诊断路径异同、实施障碍及未来方向,呼吁国际协调推进诊断创新与高质量证据。

要点

  • 20-70%哮喘患者未确诊未治疗,约30%被标签为哮喘者无病。
  • 无单一试验可靠确诊或排除哮喘,需多试验诊断。
  • 国际指南诊断路径存异,实施受症状变异、检测可及性等限制。

核心结论

  • 哮喘误诊率高,需客观证据结合症状变异支持诊断,呼吁国际协调推进诊断创新与高质量证据。

研究设计与样本

  • Personal View,总结主要指南诊断路径异同并分析实施挑战与未来方向。

主要发现

  • 20-70%哮喘患者未确诊未治疗,约30%被标签为哮喘者实际无病。
  • 国际指南在诊断试验选择、排序和解读上存在差异。
  • 多数路径强调可变呼气气流受限,但2型炎症生物标志物指导不一致。
  • 无单一试验可靠确诊或排除哮喘,需多试验诊断方法。

关键数值与推荐

  • 哮喘定义为异质性临床综合征,特征为波动性呼吸道症状和可变呼气气流受限。
  • 客观证据结合症状变异对支持哮喘诊断至关重要。
  • 多数诊断路径核心为证明可变呼气气流受限。

临床怎么用

  • 临床诊断哮喘需结合症状变异与客观检测,采用多试验策略。
  • 需关注未诊断患者及被误诊者,避免漏诊与过度诊断。
  • 实施指南推荐需克服症状时间变异、检测可及性及多病共存等障碍。

局限性

  • 原文未报告具体研究设计细节及样本量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden. Asthma is generally defined as a heterogeneous clinical syndrome characterised by fluctuating respiratory symptoms and variable expiratory airflow limitation. Despite this definition, asthma misdiagnosis remains high; 20-70% of individuals with asthma remain undiagnosed and untreated, and approximately 30% of those labelled as having asthma do not have the disease. Objective evidence, alongside variability of symptoms, is essential to support a diagnosis of asthma. However, international guidelines vary in the selection, sequencing, and interpretation of diagnostic tests, reflecting differences in methodology, health-care infrastructure, test availability, and health-economic considerations. Demonstration of variable expiratory airflow remains central to most pathways, whereas guidance on type 2 inflammatory biomarkers is inconsistent. No single test reliably confirms or excludes asthma, necessitating multi-test diagnostic approaches. Implementing guideline recommendations in routine practice is challenging. Barriers include temporal variability of symptoms and physiology, insufficient patient symptom recognition, restricted access to objective testing, and the presence of multimorbidity. This Personal View summarises the similarities and differences in diagnostic pathways across major guidelines, examines the challenges of applying these recommendations, and looks to future developments and potential solutions. We call for a coordinated international effort to advance diagnostic innovation and generate the high-quality evidence needed to transform asthma diagnosis.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Hassan W, Wang R, Mohammedalhadi A, et al. Asthma diagnosis in adults and children: challenges, future directions, and a call to action. Lancet Respir Med. 2026. PMID: 42409035. doi:10.1016/S2213-2600(26)00143-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。